Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(4S,7S,10S,13S,16S)-10-(2-Aminoethyl)-16-(2-amino-2-oxoethyl)-4-[(2S)-2-(2-amino-2-oxoethyl)pyrrolidine-1-carbonyl]-13-(carboxymethyl)-5-methyl-7-(2-methylpropyl)-6,9,12,15,18-pentaoxo-21-[(4-phenoxybenzene-1-sulfonyl)amino]-5,8,11,14,17-pentaazahenicosan-1-oic acid
ID: ALA5185612
Chembl Id: CHEMBL5185612
PubChem CID: 168282632
Max Phase: Preclinical
Molecular Formula: C46H66N10O15S
Molecular Weight: 1031.16
Associated Items: